A variety of chromosomal translocations and insertions of retroviral DNA are thought to elicit tumorigenesis by disturbing the regulation of transcription from protooncogenes (1, 2) . The archetypes of these events involve the protooncogene MYC (3), which is affected by translocations in Burkitt lymphomas and mouse plasmacytomas and by retroviral insertions in a variety of avian, feline, and murine lymphomas. The most common translocations in Burkitt lymphomas, t (8;14) , and mouse plasmacytomas, t (12;15) , have breakpoints that lie within or near MYC (4) . In some instances, however, these tumors contain variant translocations with breakpoints located more distant from and downstream of MYC (5) (6) (7) (8) (9) .
A cluster of the variant breakpoints in mouse plasmacytomas occurs in a domain known as pvt-1 (10, 11) ; the same domain is a recurrent site for insertion of retroviral DNA in lymphomas of mice (12) and rats (13, 14) , in which setting the domain has also been known as mis-i and Mlvi-J; and the counterpart in human DNA is the site of at least occasional translocations (15, 16) . One interpretation of these findings is that pvt-J marks the location ofa gene whose altered function can contribute to tumorigenesis; but until now, the postulated gene has gone undetected. Here we report the identification of a human transcription unit (designated PVT) that encompasses the human counterpart of the murine pvt-J, and we provide an initial description of how translocations in Burkitt lymphomas can affect that unit. For convenience, we refer to the transcription unit as a gene, although we have yet to prove that the unit serves any purpose.
MATERIALS AND METHODS
Molecular Clones. Molecular clones of DNA are summarized in Fig. 1 . The Y2 cDNA clone was isolated from a library prepared with RNA from the COL0320-DM cell line, as described (17) . The clone cosY14 was isolated by screening a cosmid library of human DNA with a probe prepared from the 0.16-kilobase-pair (kbp) EcoRI-Bgl II fragment at the 5' end of Y2 cDNA (E.S., unpublished work). The clone A64.26 was obtained by a "chromosome walk" that began with MYC and proceeded downstream of the gene (18) . The clone A8q3 was isolated by screening a A-phage library of human DNA with a probe for the chromosome 8 breakpoint in the translocation of the JBL2 cell line (19, 27) . The breakpoint of t(2;8) in the JBL2 Burkitt lymphoma cell line lies within the domain represented by A8q3, as diagrammed in Fig. 1 . The location of the cloned DNA downstream of MYC was determined by restriction mapping with pulsedfield electrophoresis (27) . The boundaries of the first exon of PVT in cosY14 were defined by nucleotide sequencing, the boundaries of the downstream exon in A8q3 by mapping with restriction enzymes and RNase assays with riboprobes.
Analysis of RNA. Polyadenylylated RNAs were prepared from various human cell lines and then analyzed in either of two ways. Analysis with riboprobes and RNase was performed by hybridization with a radioactive RNA probe, treatment with RNase A and T1, and analysis of the products by gel electrophoresis. Alternatively, RNAs were first fractionated by electrophoresis through agarose in the presence of formaldehyde (5 We began by isolating a cDNA clone that represents a portion of PVT (designated Y2 in Fig. 1A) , then used an EcoRl-Bgl II fragment from the 5' end of the cDNA to isolate the corresponding region of the human genome, in the form of a cosmid clone, designated cosY14 (Fig. 1B) . The To localize precisely the region of homology between PVT cDNA and PVT genomic sequences, the fragment from cosY14 that hybridized to the probe for the 5' end of the cDNA was partially sequenced (Fig. 2) . The sequences of the cDNA and the corresponding genomic region were identical through the first 177 nucleotides of the cDNA. The polarity of RNA coding sequences within the genomic locus indicated that transcription of PVT proceeds in the same direction as that of MYC. No apparent "TATA box" sequences were encountered in genomic DNA upstream to the 5' end of the cDNA. The genomic region immediately preceding the beginning of cDNA homology as well as sequences within the 5' domain of the first exon have a very high G+C content (80%).
Direction of Transcription from PVT. To confirm that the direction of transcription from PVT is the same as that of MYC, we prepared radioactive probes of RNA representing the two DNA strands of the first exon of PVT and hybridized these with RNA from several cell lines. The probe with polarity identical to that of MYC mRNA failed to react (data not shown). By contrast, hybridization ofthe complementary probe produced a heterogeneous family of RNase-resistant fragments with lengths from 140 to 210 nucleotides (Fig. 3) . Primer extension from the 78-nucleotide Sma I-Bgl II fragment of Y2 cDNA, end-labeled at the Bgl II site, gave identical results (17) . We conclude that transcription from PVT initiates at multiple sites (producing heterogeneity at the 5' ends of the RNA) and then proceeds in the same direction as transcription from MYC.
PVT Encompasses the pvt-1 Domain. In search of additional exons of PVT, we took cognizance of the fact that the first intron of PVT is >80 kbp (E.S., unpublished data). Therefore, we analyzed restriction fragments from the molecular clone A8q3 that contains DNA from ca. 220-265 kbp downstream of MYC, encompasses the counterpart of mouse pvt-1 on human chromosome 8, and contains the site of the translocation breakpoint in the Burkitt lymphoma line JBL2 (Fig. 1B) . A probe prepared with the 0.6-kbp Pst I-Acc I fragment of Y2 cDNA hybridized specifically with a 0.250-kbp Xba I-Pst I fragment within clone A8q3 (Fig. 1) . Moreover, an RNA probe representing the Xba I-Pst I fragment hybridized with cellular RNA to give a RNase-resistant fragment 135 nucleotides long (data not shown). We conclude that the human counterpart ofpvt-J contains at least one exon of PVT. That exon can be located with some accuracy by pulsed-field electrophoresis, which has been used to map the pvt-1 domain and the translocation breakpoint of the Burkitt lymphoma cell line JBL2 to a region ca. 260 kbp downstream of MYC (Fig. 1B and Cytogenetic analysis has characterized the translocations in the Burkitt lymphoma cell lines JI (6,7), BL21 (21), BL64 (22) oftranscription from PVT. Work reported elsewhere sustains this view (17) .
Chimeric RNAs Arising from PVT and Immunoglobulin Genes. A single anomaly was noticed among the RNAs that hybridized with the probe for exon 1: the presence of relatively abundant 0.8-to 1.0-kb RNAs in six of the Burkitt cell lines, but in none of the other lines examined here and elsewhere (17) . We explored the origins of these RNAs by using probes derived from regions of the PVT cDNA on the 3' side of the Pst I site (Fig. LA) . These probes reacted with all except the 1.0-and 1.7-kb normal transcripts of PVT but with none of the 0.8-to 1.0-kb RNAs (data not shown). It, therefore, appears that the immediate 5' domain of PVT is represented in the anomalous RNAs (no more than 0.45 bkp, the distance from the 5' end of Y2 cDNA to the Pst I site) and that they contain additional nucleotide sequence. We have found (unpublished work) that cDNA clones representing the anomalous RNAs hybridize with the constant regions of genes for immunoglobulin light chains-K chains for t (2;8) and A chains for t (8;22) . We conclude that the anomalous RNAs are chimeras that arise because translocation juxtaposes the 5' domain of PVT to a light chain immunoglobulin gene. The details of that juxtaposition are not yet available.
Although the chimeric RNAs occurred in all three cell lines with translocations located 140 kbp downstream of MYC and thus within PVT, they were absent from the JBL2 line, which also has a breakpoint within PVT located further downstream than the translocations that give rise to the chimeric RNAs (see Fig. 1B and Table 1 ). Even when translocations transect PVT, the multiple normal transcripts from the gene persist at low levels and presumably arise from a remaining unrearranged allele (see Table 1 ; note that the presence of the 0.8-to 1.0-kb RNAs obscures detection of the normal 1.0-kb RNA).
DISCUSSION
Three sorts of genetic damage in tumor cells may affect the chromosomal domain occupied by PVT and its murine counterpart: translocations (5-11), insertions of retroviral DNA (12, 14) , and an interstitial deletion of human chromosome 8 (16 We have detected one abnormality of PVT expression in association with translocations: the relatively abundant production of 0.8-to 1.0-kb RNAs that apparently arise from a chimeric transcriptional unit that includes the 5' domain of PVT and constant regions of immunoglobulin light chain genes. The chimera is formed by translocation that juxtaposes the 5' domain of PVT on chromosome 8 to an immunoglobulin constant region on either chromosome 2 (K light chain) or chromosome 22 (A light chain). To explain the abundance of these RNAs, we suggest that translocation has brought the promoter for PVT under the influence of an enhancer for an immunoglobulin gene. We have yet to determine the full nucleotide sequence for any ofthe chimeric RNAs and, thus, do not know whether they encode proteins that might contribute to tumorigenesis.
The significance of PVT in tumorigenesis deserves further exploration. Both chromosomal translocations and retroviral insertions may cluster in or near the gene in a variety of lymphoid tumors. Clustering of this sort is likely to result from selection for a biological effect. We hope to gain insight into this conundrum by comparing the effects of retroviral insertions on the expression of PVT with those of translocation. Identification and isolation of the murine equivalent of PVT will make this comparison possible.
